June 10 - Canada and India sign MOU to treat infectious diseases:
Canada’s International Consortium on Anti-Virals (ICAV) and the Indian Council of Medical Research (ICMR) signed a Memorandum of Understanding for Cooperation and the Acceleration of Development of Anti-Infective Therapies.
This agreement is aimed at developing a collaborative program for the treatment of major infectious diseases, particularly from neglected, newly-emerging and re-emerging viral, bacterial and parasitic threats.
Under this MOU, the ICAV India secretariat will be established in Pune at the National AIDS Research Institute, India.
Canada House in Delhi in the presence of the acting High Commissioner, Jess Dutton
A few words about usThe International Consortium on Anti-Virals (ICAV) is a not-for-profit drug development organization dedicated to the discovery and development of anti-microbial therapies for neglected and emerging diseases.
ICAV's goal is to accelerate the delivery of drugs to patients that are effective and accessible to all patients in need.
News from the World Health Organization
|WHO disease outbreak news|